CPIX
NASDAQ
US
Cumberland Pharmaceuticals Inc. - Common Stock
$3,17
▲ +$0,07
(+2,26%)
Vol. 81K
7
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$59.5M
ROE
-12,6%
Margine
-8,1%
D/E
20,06
Beta
-0,44
52W
$2–$7
Consenso Wall Street
6 analisti · Apr 20260
Acquisto forte
0
Compra
3
Mantieni
1
Vendi
2
Vendita forte
0,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 0,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | — | $-0,01 | — |
| Set 2025 | — | $-0,06 | — |
| Giu 2025 | — | $0,02 | — |
| Mar 2025 | — | $0,16 | — |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $10.4M | $11.7M | $10.8M | $8.3M | $13.7M |
| Utile netto | — | -$1.9M | $1.3M | -$741K | -$1.9M | -$1.4M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -11.2% | -11.2% | -11.2% | -11.2% | -12.6% | -12.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -6.8% | -7.0% | -7.0% | -7.0% | -8.1% | -8.1% |
| Gross Margin | 81.4% | 84.0% | 84.0% | 84.0% | 84.5% | 84.5% |
| D/E Ratio | 18.72 | 18.72 | 18.72 | 18.72 | 20.06 | 20.06 |
| Current Ratio | 1.30 | 1.30 | 1.30 | 1.30 | 1.23 | 1.23 |
Rapporti chiave
ROA (TTM)
-4,8%
P/S (TTM)
1,44
P/B
1,5
EPS (TTM)
$-0,23
CF/Share
$0,12
Crescita ricavi 3A
+1,7%
52W High
$7,25
52W Low
$1,85
$1,85
Intervallo 52 settimane
$7,25
Salute finanziaria
Flusso di cassa libero
-$41K
Debito netto
-$1.3M
Liquidità
$11.4M
Debito totale
$10.2M
Aggiornato al Dic 31, 2025
Як CPIX виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Micro-cap Pharmaceuticals (All) · 171 компаній
Оцінка CPIX vs аналоги Pharmaceuticals
P/E
—
▼
0%
sotto
peer
(22,4)
vs Peer
vs Settore
Sottovalutato
P/S
1,4
▼
71%
sotto
peer
(5,0)
vs Peer
vs Settore
Sottovalutato
P/B
1,5
▼
31%
sotto
peer
(2,1)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(2,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість CPIX vs аналоги Pharmaceuticals
ROE
-12,6%
▲
77%
sopra
peer
(-54,3%)
vs Peer
vs Settore
Top livello
Net margin
-8,1%
▲
83%
sopra
peer
(-47,4%)
vs Peer
vs Settore
Sotto media
Валова маржа
84,5%
▲
24%
sopra
peer
(68,3%)
vs Peer
vs Settore
Debole
ROA
-4,8%
▲
87%
sopra
peer
(-37,4%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя CPIX vs аналоги Pharmaceuticals
D/E ratio
20,1
▲
1203%
sopra
peer
(1,5)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
1,2
▼
63%
sotto
peer
(3,4)
vs Peer
vs Settore
Liquidità bassa
Beta
-0,4
▼
147%
sotto
peer
(0,9)
vs Peer
vs Settore
Più volatile
Радар фундаменталів CPIX
CPIX
Mediana peer
Industria
CPIX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
CPIX vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
GALANTE JOSEPH C.
Director · Mar 18
1800 shs
BROWN MARTIN S JR
Director · Mar 18
1800 shs
JONES JAMES R
Director · Mar 18
1800 shs
YOUNG CAROLINE R
Director · Mar 18
1800 shs
KROGULSKI KENNETH J
Director · Mar 18
5800 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 13,73%Ikarian Capital, LLC
3,72%
$1.7M
Renaissance Technologies, L…
3,16%
$1.4M
Vanguard Group Inc
2,75%
$1.3M
Perceptive Advisors Llc
2,28%
$1.0M
Dimensional Fund Advisors LP
1,82%
$836K
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora